Navigating the ‘grey areas’: Australian medical travellers in China's stem cell bionetwork

Abstract

The last decade has seen a marked rise in the phenomenon of the so-called stem cell tourism, whereby people travel from their home countries to access unproven stem cell treatments abroad. Despite increasing attempts on an international level from regulators, policy-makers and scientists to deter people from undergoing potentially harmful treatments, patient demand persists. Over the last decade, China has emerged as a leading destination for people seeking such treatments, where providers of treatments operate in varying ‘shades of grey’. While Chinese government intervention has had some impact on the availability of treatments within China, top-down regulatory measures face limitations co..